| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |